First Time Loading...

Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.3 USD -0.26% Market Closed
Updated: May 13, 2024
TARO
/
Income Statement
/
Interest Income Expense

Taro Pharmaceutical Industries Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Taro Pharmaceutical Industries Ltd
Interest Income Expense Peer Comparison

Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Interest Income Expense
$48.5m
CAGR 3-Years
23%
CAGR 5-Years
-10%
CAGR 10-Years
18%
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Interest Income Expense
-$991m
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
I
InterCure Ltd
TASE:INCR
Interest Income Expense
-₪24.2m
CAGR 3-Years
-117%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Interest Income Expense
$9.7m
CAGR 3-Years
126%
CAGR 5-Years
120%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Interest Income Expense
-₪12.2m
CAGR 3-Years
-17%
CAGR 5-Years
-22%
CAGR 10-Years
-6%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Interest Income Expense
-₪1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Interest Income Expense?
Interest Income Expense
48.5m USD

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Interest Income Expense amounts to 48.5m USD.

What is Taro Pharmaceutical Industries Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
18%

Over the last year, the Interest Income Expense growth was 257%. The average annual Interest Income Expense growth rates for Taro Pharmaceutical Industries Ltd have been 23% over the past three years , -10% over the past five years , and 18% over the past ten years .

ALPHA SPREAD
Join more than 136,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.